News / Press

Biodynamik Named One Of Southern California’s “Cool Companies” For 2025

Biodynamik Named One Of Southern California’s “Cool Companies” For 2025

Biodynamik Named One Of Southern California’s “Cool Companies” For 2025…

Biodynamik Named Finalist In American Diabetes Association’s 2025 Innovation Challenge

Biodynamik Named Finalist In American Diabetes Association’s 2025 Innovation Challenge

Biodynamik Named Finalist In American Diabetes Association’s 2025 Innovation Challenge…

Biodynamik Receives U.S. FDA Clearance For XT3 System®

Biodynamik Receives U.S. FDA Clearance For XT3 System®

Biodynamik Receives U.S. FDA Clearance For XT3 System® Lake Forest,…

Biodynamik Leadership Completes Training In Transverse Tibial Bone Transport Under Renowned Dr. Qikai Hua

Biodynamik Leadership Completes Training In Transverse Tibial Bone Transport Under…

Biodynamik Leadership Completes Training In Transverse Tibial Bone Transport Under…

Biodynamik Receives Grant From National Science Foundation

Biodynamik Receives Grant From National Science Foundation

Biodynamik Receives Grant From National Science Foundation Lake Forest, CA…

Biodynamik Strengthens Innovation With U.S. Issued Patents For Tissue Distraction And Automation Systems

Biodynamik Strengthens Innovation With U.S. Issued Patents For Tissue Distraction…

Biodynamik Strengthens Innovation With U.S. Issued Patents For Tissue Distraction…

Biodynamik Receives ISO 13485 Certification And Completes MDSAP Audit

Biodynamik Receives ISO 13485 Certification And Completes MDSAP Audit

Biodynamik Receives ISO 13485 Certification And Completes MDSAP Audit Lake…

Biodynamik Receives FDA IDE Approval For Pivotal U.S. Trial Of XT3 System In Diabetic Foot Ulcers

Biodynamik Receives FDA IDE Approval For Pivotal U.S. Trial Of…

Biodynamik Receives FDA IDE Approval For Pivotal U.S. Trial Of…